Maternal Primary Carnitine Deficiency and a Novel Solute Carrier Family 22 Member 5 (SLC22A5) Mutation

Primary carnitine deficiency (PCD) is a rare autosomal recessive disorder caused by loss of function mutations in the solute carrier family 22 member 5 ( SLC22A5 ) gene that encodes a high-affinity sodium-ion–dependent organic cation transporter protein (OCTN2). Reduced carnitine transport results i...

Full description

Bibliographic Details
Main Authors: Michael Jakoby MD, MA, Amruta Jaju MD, Aundrea Marsh BS, Andrew Wilber PhD
Format: Article
Language:English
Published: SAGE Publishing 2021-05-01
Series:Journal of Investigative Medicine High Impact Case Reports
Online Access:https://doi.org/10.1177/23247096211019543
_version_ 1819094077076930560
author Michael Jakoby MD, MA
Amruta Jaju MD
Aundrea Marsh BS
Andrew Wilber PhD
author_facet Michael Jakoby MD, MA
Amruta Jaju MD
Aundrea Marsh BS
Andrew Wilber PhD
author_sort Michael Jakoby MD, MA
collection DOAJ
description Primary carnitine deficiency (PCD) is a rare autosomal recessive disorder caused by loss of function mutations in the solute carrier family 22 member 5 ( SLC22A5 ) gene that encodes a high-affinity sodium-ion–dependent organic cation transporter protein (OCTN2). Reduced carnitine transport results in diminished fatty acid oxidation in heart and skeletal muscle and carnitine wasting in urine. We present a case of PCD diagnosed in an adult female after a positive newborn screen (NBS) for PCD that was not confirmed on follow-up testing. The mother was referred for evaluation of persistent fatigue and possible hypothyroidism even though all measurements of thyroid-stimulating hormone were well within the range of 0.4 to 2.5 mIU/L expected for reproductive-age women. She was found to have unequivocally low levels of both total carnitine and carnitine esters, and genetic testing revealed compound heterozygosity for 2 SLC22A5 mutations. One mutation (c.34G>A [p.Gly12Ser]) is a known missense mutation with partial OCTN2 activity, but the other mutation (c.41G>A [p.Trp14Ter]) is previously unreported and results in a premature stop codon and truncated OCTN2. This case illustrates that some maternal inborn errors of metabolism can be identified by NBS and that maternal carnitine levels should be checked after a positive NBS test for PCD.
first_indexed 2024-12-21T23:21:40Z
format Article
id doaj.art-391c8bfa792e4ca4a4f1308d97341c65
institution Directory Open Access Journal
issn 2324-7096
language English
last_indexed 2024-12-21T23:21:40Z
publishDate 2021-05-01
publisher SAGE Publishing
record_format Article
series Journal of Investigative Medicine High Impact Case Reports
spelling doaj.art-391c8bfa792e4ca4a4f1308d97341c652022-12-21T18:46:46ZengSAGE PublishingJournal of Investigative Medicine High Impact Case Reports2324-70962021-05-01910.1177/23247096211019543Maternal Primary Carnitine Deficiency and a Novel Solute Carrier Family 22 Member 5 (SLC22A5) MutationMichael Jakoby MD, MA0Amruta Jaju MD1Aundrea Marsh BS2Andrew Wilber PhD3Southern Illinois University, Springfield, IL, USASouthern Illinois University, Springfield, IL, USASouthern Illinois University, Springfield, IL, USASouthern Illinois University, Springfield, IL, USAPrimary carnitine deficiency (PCD) is a rare autosomal recessive disorder caused by loss of function mutations in the solute carrier family 22 member 5 ( SLC22A5 ) gene that encodes a high-affinity sodium-ion–dependent organic cation transporter protein (OCTN2). Reduced carnitine transport results in diminished fatty acid oxidation in heart and skeletal muscle and carnitine wasting in urine. We present a case of PCD diagnosed in an adult female after a positive newborn screen (NBS) for PCD that was not confirmed on follow-up testing. The mother was referred for evaluation of persistent fatigue and possible hypothyroidism even though all measurements of thyroid-stimulating hormone were well within the range of 0.4 to 2.5 mIU/L expected for reproductive-age women. She was found to have unequivocally low levels of both total carnitine and carnitine esters, and genetic testing revealed compound heterozygosity for 2 SLC22A5 mutations. One mutation (c.34G>A [p.Gly12Ser]) is a known missense mutation with partial OCTN2 activity, but the other mutation (c.41G>A [p.Trp14Ter]) is previously unreported and results in a premature stop codon and truncated OCTN2. This case illustrates that some maternal inborn errors of metabolism can be identified by NBS and that maternal carnitine levels should be checked after a positive NBS test for PCD.https://doi.org/10.1177/23247096211019543
spellingShingle Michael Jakoby MD, MA
Amruta Jaju MD
Aundrea Marsh BS
Andrew Wilber PhD
Maternal Primary Carnitine Deficiency and a Novel Solute Carrier Family 22 Member 5 (SLC22A5) Mutation
Journal of Investigative Medicine High Impact Case Reports
title Maternal Primary Carnitine Deficiency and a Novel Solute Carrier Family 22 Member 5 (SLC22A5) Mutation
title_full Maternal Primary Carnitine Deficiency and a Novel Solute Carrier Family 22 Member 5 (SLC22A5) Mutation
title_fullStr Maternal Primary Carnitine Deficiency and a Novel Solute Carrier Family 22 Member 5 (SLC22A5) Mutation
title_full_unstemmed Maternal Primary Carnitine Deficiency and a Novel Solute Carrier Family 22 Member 5 (SLC22A5) Mutation
title_short Maternal Primary Carnitine Deficiency and a Novel Solute Carrier Family 22 Member 5 (SLC22A5) Mutation
title_sort maternal primary carnitine deficiency and a novel solute carrier family 22 member 5 slc22a5 mutation
url https://doi.org/10.1177/23247096211019543
work_keys_str_mv AT michaeljakobymdma maternalprimarycarnitinedeficiencyandanovelsolutecarrierfamily22member5slc22a5mutation
AT amrutajajumd maternalprimarycarnitinedeficiencyandanovelsolutecarrierfamily22member5slc22a5mutation
AT aundreamarshbs maternalprimarycarnitinedeficiencyandanovelsolutecarrierfamily22member5slc22a5mutation
AT andrewwilberphd maternalprimarycarnitinedeficiencyandanovelsolutecarrierfamily22member5slc22a5mutation